{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:20:58Z","timestamp":1793064058292,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>In malignant hypertension, far more severe kidney injury occurs than in the \u201cbenign\u201d form of the disease. The role of high blood pressure and the renin\u2013angiotensin\u2013aldosterone system is well recognized, but the pathogenesis of the renal injury of malignant hypertension (MH) remains incompletely understood. Using the rat model of two-kidney, one-clip renovascular hypertension in which some but not all animals develop MH, we performed a transcriptomic analysis of gene expression by RNA sequencing to identify transcriptional changes in the kidney cortex specific for MH. Differential gene expression was assessed in three groups: MH, non-malignant hypertension (NMH), and normotensive, sham-operated controls. To distinguish MH from NMH, we considered two factors: weight loss and typical renovascular lesions. Mean blood pressure measured intraarterially was elevated in MH (220\u2009\u00b1\u20096.5\u00a0mmHg) as well as in NMH (192\u2009\u00b1\u20096.4\u00a0mmHg), compared to controls (119\u2009\u00b1\u20091.7\u00a0mmHg, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Eight hundred eighty-six genes were exclusively regulated in MH only. Principal component analysis revealed a separated clustering of the three groups. The data pointed to an upregulation of many inflammatory mechanisms in MH including pathways which previously attracted relatively little attention in the setting of hypertensive kidney injury: Transcripts from all three complement activation pathways were upregulated in MH compared to NMH but not in NMH compared with controls; immunohistochemistry confirmed complement deposition in MH exclusively. The expression of chemokines attracting neutrophil granulocytes (CXCL6) and infiltration of myeloperoxidase-positive cells were increased only in MH rats. The data suggest that these pathways, especially complement deposition, may contribute to kidney injury under MH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key messages<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>The most severe hypertension-induced kidney injury occurs in malignant hypertension.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>In a rat model of malignant hypertension, we assessed transcriptional responses in the kidney exposed to high blood pressure. A broad stimulation of inflammatory mechanisms was observed, but a few specific pathways were activated only in the malignant form of the disease, notably activation of the complement cascades.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Complement inhibitors may alleviate the thrombotic microangiopathy of malignant hypertension even in the absence of primary complement abnormalities.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00109-021-02133-8","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T18:08:42Z","timestamp":1631729322000},"page":"1727-1740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RNA sequencing reveals induction of specific renal inflammatory pathways in a rat model of malignant hypertension"],"prefix":"10.1007","volume":"99","author":[{"given":"Carlos","family":"Menendez-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Cordasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian B.","family":"Fahlbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif B.","family":"Ekici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Velkeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"W\u00f6lfle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-1308","authenticated-orcid":false,"given":"Andrea","family":"Hartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl F.","family":"Hilgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"2133_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937\u2013952. https:\/\/doi.org\/10.1016\/S0140-6736(04)17018-9","journal-title":"Lancet"},{"key":"2133_CR2","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1161\/CIRCULATIONAHA.114.010676","volume":"130","author":"BM Egan","year":"2014","unstructured":"Egan BM, Li J, Hutchison FN, Ferdinand KC (2014) Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation 130:1692\u20131699. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010676","journal-title":"Circulation"},{"key":"2133_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","volume":"55","author":"P Muntner","year":"2010","unstructured":"Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, O\u2019Connor A, Perumal K, Rahman M, Steigerwalt S, Teal V, Townsend R, Weir M, Wright JT Jr (2010) Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 55:441\u2013451. https:\/\/doi.org\/10.1053\/j.ajkd.2009.09.014","journal-title":"Am J Kidney Dis"},{"key":"2133_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/jhh.2015.112","volume":"30","author":"A Cremer","year":"2016","unstructured":"Cremer A, Amraoui F, Lip GY, Morales E, Rubin S, Segura J, Van den Born BJ, Gosse P (2016) From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Hum Hypertens 30:463\u2013466. https:\/\/doi.org\/10.1038\/jhh.2015.112","journal-title":"J Hum Hypertens"},{"key":"2133_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1161\/HYPERTENSIONAHA.114.03609","volume":"64","author":"KA Griffin","year":"2014","unstructured":"Griffin KA, Polichnowski A, Litbarg N, Picken M, Venkatachalam MA, Bidani AK (2014) Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model. Hypertension 64:801\u2013807. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03609","journal-title":"Hypertension"},{"key":"2133_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000490201","volume":"140","author":"M Demeulenaere","year":"2018","unstructured":"Demeulenaere M, Devreese K, Vanbelleghem H, De Zaeytijd J, Vande Walle J, Van Biesen W, Van Laecke S (2018) Thrombomodulin and endothelial dysfunction: a disease-modifier shared between malignant hypertension and atypical hemolytic uremic syndrome. Nephron 140:63\u201373. https:\/\/doi.org\/10.1159\/000490201","journal-title":"Nephron"},{"key":"2133_CR7","first-page":"173","volume":"80","author":"C Isaacson","year":"1991","unstructured":"Isaacson C, Milne FJ, van Niekerk I, Kenyon MR, Mzamane DV (1991) The renal histopathology of essential malignant hypertension in black South Africans. S Afr Med J 80:173\u2013176","journal-title":"S Afr Med J"},{"key":"2133_CR8","doi-asserted-by":"publisher","unstructured":"Helmchen U, Bohle RM, Kneissler U, Groene HJ (1984) Intrarenal arteries in rats with early two-kidney, one clip hypertension. Hypertension 6:III87\u201392.\u00a0https:\/\/doi.org\/10.1161\/01.hyp.6.6_pt_2.iii87","DOI":"10.1161\/01.hyp.6.6_pt_2.iii87"},{"key":"2133_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/01.hyp.35.2.587","volume":"35","author":"E Mervaala","year":"2000","unstructured":"Mervaala E, Muller DN, Schmidt F, Park JK, Gross V, Bader M, Breu V, Ganten D, Haller H, Luft FC (2000) Blood pressure-independent effects in rats with human renin and angiotensinogen genes. Hypertension 35:587\u2013594. https:\/\/doi.org\/10.1161\/01.hyp.35.2.587","journal-title":"Hypertension"},{"key":"2133_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/01.hyp.24.3.309","volume":"24","author":"AK Bidani","year":"1994","unstructured":"Bidani AK, Griffin KA, Plott W, Schwartz MM (1994) Renal ablation acutely transforms \u2018benign\u2019 hypertension to \u2018malignant\u2019 nephrosclerosis in hypertensive rats. Hypertension 24:309\u2013316. https:\/\/doi.org\/10.1161\/01.hyp.24.3.309","journal-title":"Hypertension"},{"key":"2133_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1152\/ajplegacy.1976.230.3.849","volume":"230","author":"J Mohring","year":"1976","unstructured":"Mohring J, Petri M, Szokol M, Haack D, Mohring B (1976) Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol 230:849\u2013857. https:\/\/doi.org\/10.1152\/ajplegacy.1976.230.3.849","journal-title":"Am J Physiol"},{"key":"2133_CR12","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/ndt\/gfl065","volume":"21","author":"A Hartner","year":"2006","unstructured":"Hartner A, Porst M, Klanke B, Cordasic N, Veelken R, Hilgers KF (2006) Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats. Nephrol Dial Transplant 21:1778\u20131785. https:\/\/doi.org\/10.1093\/ndt\/gfl065","journal-title":"Nephrol Dial Transplant"},{"key":"2133_CR13","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1161\/hc3601.095576","volume":"104","author":"KF Hilgers","year":"2001","unstructured":"Hilgers KF, Hartner A, Porst M, Veelken R, Mann JF (2001) Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: relation to kidney inflammation. Circulation 104:1436\u20131440","journal-title":"Circulation"},{"key":"2133_CR14","doi-asserted-by":"publisher","unstructured":"Hartner A, Jagusch L, Cordasic N, Amann K, Veelken R, Jacobi J, Hilgers KF (2016) Impaired neovascularization and reduced capillary supply in the malignant vs. non-malignant course of experimental renovascular hypertension. Front Physiol 7:370.\u00a0https:\/\/doi.org\/10.3389\/fphys.2016.00370","DOI":"10.3389\/fphys.2016.00370"},{"key":"2133_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/01.hyp.25.4.674","volume":"25","author":"M Mai","year":"1995","unstructured":"Mai M, Hilgers KF, Wagner J, Mann JF, Geiger H (1995) Expression of angiotensin-converting enzyme in renovascular hypertensive rat kidney. Hypertension 25:674\u2013678. https:\/\/doi.org\/10.1161\/01.hyp.25.4.674","journal-title":"Hypertension"},{"key":"2133_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.kint.2016.09.028","volume":"91","author":"IN Schellinger","year":"2017","unstructured":"Schellinger IN, Cordasic N, Panesar J, Buchholz B, Jacobi J, Hartner A, Klanke B, Jakubiczka-Smorag J, Burzlaff N, Heinze E, Warnecke C, Raaz U, Willam C, Tsao PS, Eckardt KU, Amann K, Hilgers KF (2017) Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease. Kidney Int 91:616\u2013627. https:\/\/doi.org\/10.1016\/j.kint.2016.09.028","journal-title":"Kidney Int"},{"key":"2133_CR17","doi-asserted-by":"publisher","unstructured":"Mocker A, Hilgers\u00a0KF,  Cordasic\u00a0N,  Wachtveitl\u00a0R,  Menendez-Castro\u00a0C,  Woelfle\u00a0J,  Hartner\u00a0A,  Fahlbusch\u00a0FB\u00a0(2019) Renal chemerin expression is induced in models of hypertensive nephropathy and glomerulonephritis and correlates with markers of inflammation and fibrosis. Int J Mol Sci 20.\u00a0https:\/\/doi.org\/10.3390\/ijms20246240","DOI":"10.3390\/ijms20246240"},{"key":"2133_CR18","doi-asserted-by":"publisher","unstructured":"Hrdlickova\u00a0R,  Toloue\u00a0M,  Tian\u00a0B\u00a0(2017) RNA-Seq methods for transcriptome analysis Wiley Interdiscip. Rev RNA 8.\u00a0https:\/\/doi.org\/10.1002\/wrna.1364","DOI":"10.1002\/wrna.1364"},{"key":"2133_CR19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/01.hyp.22.5.754","volume":"22","author":"M Mai","year":"1993","unstructured":"Mai M, Geiger H, Hilgers KF, Veelken R, Mann JF, Dammrich J, Luft FC (1993) Early interstitial changes in hypertension-induced renal injury. Hypertension 22:754\u2013765. https:\/\/doi.org\/10.1161\/01.hyp.22.5.754","journal-title":"Hypertension"},{"key":"2133_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","volume":"97","author":"B Rodriguez-Iturbe","year":"2017","unstructured":"Rodriguez-Iturbe B, Pons H, Johnson RJ (2017) Role of the immune system in hypertension. Physiol Rev 97:1127\u20131164. https:\/\/doi.org\/10.1152\/physrev.00031.2016","journal-title":"Physiol Rev"},{"issue":"Suppl 1","key":"2133_CR21","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.3109\/07853890.2011.653396","volume":"44","author":"FC Luft","year":"2012","unstructured":"Luft FC, Dechend R, Muller DN (2012) Immune mechanisms in angiotensin II-induced target-organ damage. Ann Med 44(Suppl 1):S49-54. https:\/\/doi.org\/10.3109\/07853890.2011.653396","journal-title":"Ann Med"},{"key":"2133_CR22","doi-asserted-by":"publisher","unstructured":"Cavero\u00a0T,  Arjona\u00a0E,  Soto\u00a0K,  Caravaca-Fontan\u00a0F,  Rabasco\u00a0C,  Bravo\u00a0L,  Cerda\u00a0F, de la  Martin\u00a0N,  Blasco\u00a0M,  Avila\u00a0A,  Huerta\u00a0A,  Cabello\u00a0V,  Jarque\u00a0A,  Alcazar\u00a0C,  Fulladosa\u00a0X,  Carbayo\u00a0J,  Anaya\u00a0S,  Cobelo\u00a0C,  Ramos\u00a0N,  Iglesias\u00a0E,  Baltar\u00a0J,  Martinez-Gallardo\u00a0R,  Perez\u00a0L,  Morales\u00a0E, Gonzalez\u00a0R,  Macia\u00a0M,  Draibe\u00a0J,  Pallardo\u00a0L,  Quintana\u00a0LF,  Espinosa\u00a0M,  Barros\u00a0X,  Pereira\u00a0F,  Cao\u00a0M,  Moreno\u00a0JA,  Rodriguez\u00a0S,  Cordoba\u00a0de,  Praga\u00a0M\u00a0(2019) Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome. Kidney Int 96 995 1004.\u00a0https:\/\/doi.org\/10.1016\/j.kint.2019.05.014","DOI":"10.1016\/j.kint.2019.05.014"},{"key":"2133_CR23","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.kint.2016.12.009","volume":"91","author":"S Timmermans","year":"2017","unstructured":"Timmermans S, Abdul-Hamid MA, Vanderlocht J, Damoiseaux J, Reutelingsperger CP, van Paassen P (2017) Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities. Kidney Int 91:1420\u20131425. https:\/\/doi.org\/10.1016\/j.kint.2016.12.009","journal-title":"Kidney Int"},{"key":"2133_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/modpathol.2017.154","volume":"31","author":"CP Larsen","year":"2018","unstructured":"Larsen CP, Wilson JD, Best-Rocha A, Beggs ML, Hennigar RA (2018) Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy. Mod Pathol 31:488\u2013494. https:\/\/doi.org\/10.1038\/modpathol.2017.154","journal-title":"Mod Pathol"},{"key":"2133_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1365-2567.2007.02598.x","volume":"121","author":"B Coles","year":"2007","unstructured":"Coles B, Lewis R, Anning PB, Morton J, Baalasubramanian S, Morgan BP, O\u2019Donnell VB (2007) CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice. Immunology 121:518\u2013525. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02598.x","journal-title":"Immunology"},{"key":"2133_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/ATVBAHA.114.304927","volume":"35","author":"CC Ruan","year":"2015","unstructured":"Ruan CC, Ge Q, Li Y, Li XD, Chen DR, Ji KD, Wu YJ, Sheng LJ, Yan C, Zhu DL, Gao PJ (2015) Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice. Arterioscler Thromb Vasc Biol 35:598\u2013606. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304927","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2133_CR27","doi-asserted-by":"publisher","first-page":"F1747","DOI":"10.1152\/ajprenal.00370.2018","volume":"315","author":"E Negishi","year":"2018","unstructured":"Negishi E, Fukuda N, Otsuki T, Katakawa M, Komatsu K, Chen L, Tanaka S, Kobayashi H, Hatanaka Y, Ueno T, Endo M, Mashimo T, Nishiyama A, Abe M (2018) Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive rats. Am J Physiol Renal Physiol 315:F1747\u2013F1758. https:\/\/doi.org\/10.1152\/ajprenal.00370.2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"2133_CR28","doi-asserted-by":"publisher","first-page":"H349","DOI":"10.1152\/ajpheart.00759.2016","volume":"312","author":"UO Wenzel","year":"2017","unstructured":"Wenzel UO, Bode M, Kohl J, Ehmke H (2017) A pathogenic role of complement in arterial hypertension and hypertensive end organ damage. Am J Physiol Heart Circ Physiol 312:H349\u2013H354. https:\/\/doi.org\/10.1152\/ajpheart.00759.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2133_CR29","doi-asserted-by":"publisher","first-page":"F1356","DOI":"10.1152\/ajprenal.00040.2016","volume":"310","author":"S Weiss","year":"2016","unstructured":"Weiss S, Rosendahl A, Czesla D, Meyer-Schwesinger C, Stahl RA, Ehmke H, Kurts C, Zipfel PF, Kohl J, Wenzel UO (2016) The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension. Am J Physiol Renal Physiol 310:F1356\u2013F1365. https:\/\/doi.org\/10.1152\/ajprenal.00040.2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2133_CR30","doi-asserted-by":"publisher","first-page":"8598","DOI":"10.1038\/s41598-018-26870-y","volume":"8","author":"S Kashyap","year":"2018","unstructured":"Kashyap S, Osman M, Ferguson CM, Nath MC, Roy B, Lien KR, Nath KA, Garovic VD, Lerman LO, Grande JP (2018) Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension. Sci Rep 8:8598. https:\/\/doi.org\/10.1038\/s41598-018-26870-y","journal-title":"Sci Rep"},{"key":"2133_CR31","doi-asserted-by":"publisher","first-page":"F982","DOI":"10.1152\/ajprenal.00521.2019","volume":"318","author":"AJ Alsheikh","year":"2020","unstructured":"Alsheikh AJ, Dasinger JH, Abais-Battad JM, Fehrenbach DJ, Yang C, Cowley AW Jr, Mattson DL (2020) CCL2 mediates early renal leukocyte infiltration during salt-sensitive hypertension. Am J Physiol Renal Physiol 318:F982\u2013F993. https:\/\/doi.org\/10.1152\/ajprenal.00521.2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"2133_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1681\/ASN.2018090931","volume":"30","author":"KA Zimmerman","year":"2019","unstructured":"Zimmerman KA, Bentley MR, Lever JM, Li Z, Crossman DK, Song CJ, Liu S, Crowley MR, George JF, Mrug M, Yoder BK (2019) Single-cell RNA sequencing identifies candidate renal resident macrophage gene expression signatures across species. J Am Soc Nephrol 30:767\u2013781. https:\/\/doi.org\/10.1681\/ASN.2018090931","journal-title":"J Am Soc Nephrol"},{"key":"2133_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1084\/jem.20171773","volume":"215","author":"AE Norlander","year":"2018","unstructured":"Norlander AE, Madhur MS, Harrison DG (2018) The immunology of hypertension. J Exp Med 215:21\u201333. https:\/\/doi.org\/10.1084\/jem.20171773","journal-title":"J Exp Med"},{"key":"2133_CR34","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","volume":"204","author":"TJ Guzik","year":"2007","unstructured":"Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449\u20132460. https:\/\/doi.org\/10.1084\/jem.20070657","journal-title":"J Exp Med"},{"key":"2133_CR35","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.119.13773","volume":"75","author":"A Seniuk","year":"2020","unstructured":"Seniuk A, Thiele JL, Stubbe A, Oser P, Rosendahl A, Bode M, Meyer-Schwesinger C, Wenzel UO, Ehmke H (2020) B6.Rag1 knockout mice generated at the Jackson Laboratory in 2009 show a robust wild-type hypertensive phenotype in response to Ang II (angiotensin II). Hypertension 75:1110\u20131116. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13773","journal-title":"Hypertension"},{"key":"2133_CR36","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.930446","volume":"122","author":"A Vinh","year":"2010","unstructured":"Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ (2010) Inhibition and genetic ablation of the B7\/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122:2529\u20132537. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.930446","journal-title":"Circulation"},{"key":"2133_CR37","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1021\/bi961999z","volume":"36","author":"A Wuyts","year":"1997","unstructured":"Wuyts A, Van Osselaer N, Haelens A, Samson I, Herdewijn P, Ben-Baruch A, Oppenheim JJ, Proost P, Van Damme J (1997) Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 36:2716\u20132723. https:\/\/doi.org\/10.1021\/bi961999z","journal-title":"Biochemistry"},{"key":"2133_CR38","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/ajh\/hpv034","volume":"28","author":"X Liu","year":"2015","unstructured":"Liu X, Zhang Q, Wu H, Du H, Liu L, Shi H, Wang C, Xia Y, Guo X, Li C, Bao X, Su Q, Sun S, Wang X, Zhou M, Jia Q, Zhao H, Song K, Niu K (2015) Blood neutrophil to lymphocyte ratio as a predictor of hypertension. Am J Hypertens 28:1339\u20131346. https:\/\/doi.org\/10.1093\/ajh\/hpv034","journal-title":"Am J Hypertens"},{"key":"2133_CR39","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.113.02843","volume":"63","author":"Y Wu","year":"2014","unstructured":"Wu Y, Li Y, Zhang C, A X, Wang Y, Cui W, Li H, Du J (2014) S100a8\/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury. Hypertension 63:1241\u20131250. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02843","journal-title":"Hypertension"},{"key":"2133_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/clin.1997.4361","volume":"83","author":"W Ofosu-Appiah","year":"1997","unstructured":"Ofosu-Appiah W, Sfeir G, Smith D, Richard T (1997) Neutrophil-mediated damage to vascular endothelium in the spontaneously hypertensive rat. Clin Immunol Immunopathol 83:293\u2013301. https:\/\/doi.org\/10.1006\/clin.1997.4361","journal-title":"Clin Immunol Immunopathol"},{"key":"2133_CR41","doi-asserted-by":"publisher","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18:e3000410.\u00a0https:\/\/doi.org\/10.1371\/journal.pbio.3000410","DOI":"10.1371\/journal.pbio.3000410"},{"key":"2133_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/pr.2014.27","volume":"75","author":"C Menendez-Castro","year":"2014","unstructured":"Menendez-Castro C, Toka O, Fahlbusch F, Cordasic N, Wachtveitl R, Hilgers KF, Rascher W, Hartner A (2014) Impaired myocardial performance in a normotensive rat model of intrauterine growth restriction. Pediatr Res 75:697\u2013706. https:\/\/doi.org\/10.1038\/pr.2014.27","journal-title":"Pediatr Res"},{"key":"2133_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1152\/physiolgenomics.00124.2016","volume":"49","author":"RU Heiss","year":"2017","unstructured":"Heiss RU, Fahlbusch FB, Jacobi J, Daniel C, Ekici AB, Cordasic N, Amann K, Hartner A, Hilgers KF (2017) Blunted transcriptional response to skeletal muscle ischemia in rats with chronic kidney disease: potential role for impaired ischemia-induced angiogenesis. Physiol Genomics 49:230\u2013237. https:\/\/doi.org\/10.1152\/physiolgenomics.00124.2016","journal-title":"Physiol Genomics"},{"key":"2133_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.mam.2005.12.003","volume":"27","author":"S Fleige","year":"2006","unstructured":"Fleige S, Pfaffl MW (2006) RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 27:126\u2013139. https:\/\/doi.org\/10.1016\/j.mam.2005.12.003","journal-title":"Mol Aspects Med"},{"key":"2133_CR45","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1097\/01.asn.0000076078.50889.43","volume":"14","author":"K Matsui","year":"2003","unstructured":"Matsui K, Nagy-Bojarsky K, Laakkonen P, Krieger S, Mechtler K, Uchida S, Geleff S, Kang DH, Johnson RJ, Kerjaschki D (2003) Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 14:1981\u20131989. https:\/\/doi.org\/10.1097\/01.asn.0000076078.50889.43","journal-title":"J Am Soc Nephrol"},{"key":"2133_CR46","volume-title":"Straightforward statistics for the behavioral sciences","author":"JD Evans","year":"1996","unstructured":"Evans JD (1996) Straightforward statistics for the behavioral sciences. Brooks\/Cole Pub. Co., Pacific Grove"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02133-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-021-02133-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02133-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T11:03:20Z","timestamp":1637147000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-021-02133-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2133"],"URL":"https:\/\/doi.org\/10.1007\/s00109-021-02133-8","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the animal ethics committee of the governmental authorities (Regierung von Unterfranken). Approval number: AZ54-2532.1\u201351\/12.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All procedures performed on animals were done in compliance with the DIRECTIVE 304 2010\/63\/EU of the European Parliament.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on welfare of animals"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}